Definium Therapeutics (DFTX) Q1 2026 Earnings

26FebConfirmed
Q4 2025
Q1 2026
-0.78
-0.68
-0.58
-0.48

Details

Expected EPS
-0.483679
Actual EPS
-0.51
Surprise EPS
-0.03
Surprise Percent
+5.44%

Description

Definium Therapeutics (DFTX) has reported earnings of -0.51 per share for Q1 2026.

0 Comments

Share your thoughts